McDermott Will & Emery advised Egle Therapeutics on the deal. Gide advised the pool of investors, while Morgan, Lewis & Bockius advised Takeda Ventures.Egle Therapeutics, which…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
